JP2019060706A5 - - Google Patents

Download PDF

Info

Publication number
JP2019060706A5
JP2019060706A5 JP2017185200A JP2017185200A JP2019060706A5 JP 2019060706 A5 JP2019060706 A5 JP 2019060706A5 JP 2017185200 A JP2017185200 A JP 2017185200A JP 2017185200 A JP2017185200 A JP 2017185200A JP 2019060706 A5 JP2019060706 A5 JP 2019060706A5
Authority
JP
Japan
Prior art keywords
expression level
gene
prdm14
correlate
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017185200A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019060706A (ja
JP6898617B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2017185200A priority Critical patent/JP6898617B2/ja
Priority claimed from JP2017185200A external-priority patent/JP6898617B2/ja
Priority to US16/650,415 priority patent/US20210208148A1/en
Priority to EP18861512.4A priority patent/EP3690444A4/en
Priority to PCT/JP2018/035395 priority patent/WO2019065609A1/ja
Publication of JP2019060706A publication Critical patent/JP2019060706A/ja
Publication of JP2019060706A5 publication Critical patent/JP2019060706A5/ja
Application granted granted Critical
Publication of JP6898617B2 publication Critical patent/JP6898617B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017185200A 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法 Expired - Fee Related JP6898617B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2017185200A JP6898617B2 (ja) 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法
US16/650,415 US20210208148A1 (en) 2017-09-26 2018-09-25 Method for confirming prdm14 expression
EP18861512.4A EP3690444A4 (en) 2017-09-26 2018-09-25 PROCEDURE FOR CONFIRMING EXPRESSION OF PRDM14
PCT/JP2018/035395 WO2019065609A1 (ja) 2017-09-26 2018-09-25 Ｐｒｄｍ１４発現を確認する方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017185200A JP6898617B2 (ja) 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法

Publications (3)

Publication Number Publication Date
JP2019060706A JP2019060706A (ja) 2019-04-18
JP2019060706A5 true JP2019060706A5 (https=) 2020-11-05
JP6898617B2 JP6898617B2 (ja) 2021-07-07

Family

ID=65902885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017185200A Expired - Fee Related JP6898617B2 (ja) 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法

Country Status (4)

Country Link
US (1) US20210208148A1 (https=)
EP (1) EP3690444A4 (https=)
JP (1) JP6898617B2 (https=)
WO (1) WO2019065609A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230127134A1 (en) * 2021-09-20 2023-04-27 Droplet Biosciences, Inc. Methods for cancer treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5219818B2 (https=) 1973-03-30 1977-05-31
WO2008038832A1 (en) * 2006-09-27 2008-04-03 Sapporo Medical University Therapeutic agent, detection method and detection kit for breast cancer and ovarian cancer
WO2011085163A2 (en) * 2010-01-08 2011-07-14 The Regents Of The University Of California Protein markers for lung cancer detection and methods of using thereof
WO2012054732A2 (en) * 2010-10-20 2012-04-26 Rush University Medical Center Lung cancer tests
JP6683986B2 (ja) * 2013-07-10 2020-04-22 国立大学法人 東京大学 がん幹細胞分子マーカー
US20150038365A1 (en) * 2013-08-01 2015-02-05 Meso Scale Technologies, Llc Lung cancer biomarkers
JP7136697B2 (ja) * 2015-09-25 2022-09-13 プロビスタ ダイアグノスティックス インコーポレイテッド デンスブレストを有する女性における乳癌の検出のためのバイオマーカー

Similar Documents

Publication Publication Date Title
JP7458678B2 (ja) タンパク質同定のためのデコーディングアプローチ方法
CN104704364B (zh) 用于先兆子痫和/或hellp综合征的预测或早期检测的生物标记物测试
EA201891580A1 (ru) Применение размера фрагмента бесклеточной днк для определения вариаций числа копий
EP4372383A3 (en) Methods and systems for protein identification
HRP20191182T1 (hr) Identifikacija tumorsko-zaštitnih epitopa za liječenje karcinoma
CA2798517A1 (en) Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments
Leung et al. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies
EP4254417A3 (en) Using nucleic acid size range for noninvasive prenatal testing and cancer detection
Jiang et al. Gestational age assessment by methylation and size profiling of maternal plasma DNA: a feasibility study
JP2020533595A5 (https=)
WO2021072187A3 (en) Ran proteins as biomarkers in cag/ctg expansion disorders
Uhlen Response to: Should we ignore western blots when selecting antibodies for other applications?
Park et al. Optimized combination of multiple biomarkers to improve diagnostic accuracy in male fertility
JP2017516501A (ja) 肺がんのタイピング法
Regin et al. Complex aneuploidy triggers autophagy and p53-mediated apoptosis and impairs the second lineage segregation in human preimplantation embryos
WO2023245827A1 (zh) 一种鉴定样本中间充质干细胞的组织来源的方法及其用途
MX2025003617A (es) Metodos y productos para la identificacion de biomarcadores
JP2019060706A5 (https=)
JP2018525356A5 (https=)
WO2019089858A3 (en) Methods of assessing or monitoring a response to a cell therapy
JP2023551795A (ja) 非ヒトメタゲノム経路解析によるがん診断および分類
GB2582074A (en) Methods and systems for detecting tissue conditions
WO2021247710A3 (en) Stem-cell based biomarker discovery
WO2014151079A8 (en) Ratio based biomarkers and methods of use thereof for the detection and prognosis of cancer
JP2019007971A5 (https=)